Abstract
Background/Aims
Caustic ingestion can cause severe injury to upper gastrointestinal tract. There were few studies about clinical characteristics and treatments of caustic injury in Korea. We investigated the changes in clinical features of caustic injury over the past 20 years including pattern of endoscopic mucosal injury and treatment modality.
Methods
This study was a retrospective review of medical records from patients with caustic injury from September 1993 through December 2012. Patients were classified into two groups based on the year when caustic ingestion occurred: patients who visited the hospital from 1993 to 2002 (early group) and patients who visited the hospital from 2003 to 2012 (late group).
Results
A total 140 patients were included (early group [n=50] vs. late group [n=90]). Annual number of caustic ingestions did not show decreasing tendency over the past 20 years. Alkali ingestion increased (20.0% vs. 65.6%, p<0.001) and cases with more than grade 2b of esophageal mucosal injury decreased (41.3% vs. 20.7%, p=0.012) in late group. There were no differences between two groups in sex, age, proportion of accidental ingestion, and systemic/gastrointestinal complications. Use of gastric lavage (p<0.01) and broad spectrum antibiotics (p=0.03) decreased in late group. However, there was no difference in use of steroid between two groups.
References
2. Goldman LP, Weigert JM. Corrosive substance ingestion: a review. Am J Gastroenterol. 1984; 79:85–90.
3. Cello JP, Fogel RP, Boland CR. Liquid caustic ingestion. Spectrum of injury. Arch Intern Med. 1980; 140:501–504.
5. Bautista Casasnovas A, Estevez Martinez E, Varela Cives R, Villanueva Jeremias A, Tojo Sierra R, Cadranel S. A retrospective analysis of ingestion of caustic substances by children. Ten-year statistics in Galicia. Eur J Pediatr. 1997; 156:410–414.
6. Arévalo-Silva C, Eliashar R, Wohlgelernter J, Elidan J, Gross M. Ingestion of caustic substances: a 15-year experience. Laryngo-scope. 2006; 116:1422–1426.
7. Nuutinen M, Uhari M, Karvali T, Kouvalainen K. Consequences of caustic ingestions in children. Acta Paediatr. 1994; 83:1200–1205.
8. Poley JW, Steyerberg EW, Kuipers EJ, et al. Ingestion of acid and alkaline agents: outcome and prognostic value of early upper endoscopy. Gastrointest Endosc. 2004; 60:372–377.
9. Ertekin C, Alimoglu O, Akyildiz H, Guloglu R, Taviloglu K. The results of caustic ingestions. Hepatogastroenterology. 2004; 51:1397–1400.
10. Zargar SA, Kochhar R, Nagi B, Mehta S, Mehta SK. Ingestion of strong corrosive alkalis: spectrum of injury to upper gastrointestinal tract and natural history. Am J Gastroenterol. 1992; 87:337–341.
11. Zargar SA, Kochhar R, Nagi B, Mehta S, Mehta SK. Ingestion of corrosive acids. Spectrum of injury to upper gastrointestinal tract and natural history. Gastroenterology. 1989; 97:702–707.
12. Zargar SA, Kochhar R, Mehta S, Mehta SK. The role of fiberoptic endoscopy in the management of corrosive ingestion and modi-fied endoscopic classification of burns. Gastrointest Endosc. 1991; 37:165–169.
13. Cheng HT, Cheng CL, Lin CH, et al. Caustic ingestion in adults: the role of endoscopic classification in predicting outcome. BMC Gastroenterol. 2008; 8:31.
14. Salzman M, O'Malley RN. Updates on the evaluation and management of caustic exposures. Emerg Med Clin North Am. 2007; 25:459–476.
15. Chibishev A, Pereska Z, Chibisheva V, Simonovska N. Corrosive poisonings in adults. Mater Sociomed. 2012; 24:125–130.
16. Rao RB, Hoffman RS. Caustics and batteries. Goldfrank LR, Norwalk CT, editors. Goldfrank's toxicologic emergencies. 6th ed.Norwalk: Appleton & Lange;1998. p. 1399–1428.
17. Contini S, Scarpignato C. Caustic injury of the upper gastrointestinal tract: a comprehensive review. World J Gastroenterol. 2013; 19:3918–3930.
18. Pelclová D, Navrátil T. Do corticosteroids prevent oesophageal stricture after corrosive ingestion? Toxicol Rev. 2005; 24:125–129.
19. Yeom HJ, Shim KN, Kim SE, et al. Clinical characteristics and pre-disposing factors for complication of caustic injury of the upper digestive tract. Korean J Med. 2006; 70:371–377.
20. Yoon KW, Park MH, Park GS, et al. A clinical study on the upper gastrointestinal tract injury caused by corrosive agent. Korean J Gastrointest Endosc. 2001; 23:82–87.
21. Kim YS, Choi SM, Kim HM, Youn CS, Park KN. The clinical characteristics and risk factors of upper digestive lesions that are due to ingestion of caustic material. J Korean Soc Clin Toxicol. 2009; 7:113–120.
22. Gumaste VV, Dave PB. Ingestion of corrosive substances by adults. Am J Gastroenterol. 1992; 87:1–5.
23. Satar S, Topal M, Kozaci N. Ingestion of caustic substances by adults. Am J Ther. 2004; 11:258–261.
25. Khi W, Kim JS, Baek KJ, et al. A retrospective review of patients who ingested liquid household bleach containing sodium hypochlorite. J Korean Soc Emerg Med. 2005; 16:298–303.
26. Kim GB, Cheon YJ, Choi YH. Is the emergent endoscopy necessary for the patients who ingested liquid household bleach containing sodium hypochlorite? J Korean Soc Emerg Med. 2006; 17:351–356.
28. Watson WA, Litovitz TL, Rodgers GC Jr, et al. 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2003; 21:353–421.
29. Racioppi F, Daskaleros PA, Besbelli N, et al. Household bleaches based on sodium hypochlorite: review of acute toxicology and poison control center experience. Food Chem Toxicol. 1994; 32:845–861.
30. Trabelsi M, Loukhil M, Boukthir S, Hammami A, Bennaceur B. Accidental ingestion of caustics in Tunisian children. Report of 125 cases. Pediatrie. 1990; 45:801–805.
31. Ross MP, Spiller HA. Fatal ingestion of sodium hypochlorite bleach with associated hypernatremia and hyperchloremic met-abolic acidosis. Vet Hum Toxicol. 1999; 41:82–86.
32. Park JS, Min JH, Kim H, Lee SW. Esophageal perforation and me-diastinitis after suicidal ingestion of 4.5% sodium hypochlorite [correction of hydrochlorite] bleach. Clin Toxicol (Phila). 2011; 49:765–766.
33. de Jong AL, Macdonald R, Ein S, Forte V, Turner A. Corrosive esophagitis in children: a 30-year review. Int J Pediatr Otorhinolaryngol. 2001; 57:203–211.
35. Peter M, Loeb-Abram M. Caustic injury to the upper gastrointestinal tract. Sleisenger MH, Fordtran JS, Feldman M, Scharschmidt B, editors. Sleisenger & Fordtran's gastroincestinal and liver disease. 6th ed.Eisenstein: W.B. Saunders;1998. p. 335–342.
36. Heyerdahl F, Hovda KE, Bjornaas MA, et al. Pre-hospital treatment of acute poisonings in Oslo. BMC Emerg Med. 2008; 8:15.
37. Krey H. On the treatment of corrosive lesions in the oesophagus; an experimental study. Acta Otolaryngol Suppl. 1952; 102:1–49.
38. Boukthir S, Fetni I, Mrad SM, Mongalgi MA, Debbabi A, Barsaoui S. High doses of steroids in the management of caustic esophageal burns in children. Arch Pediatr. 2004; 11:13–17.
39. Gün F, Abbasoğ lu L, Celik A, Salman ET. Early and late term management in caustic ingestion in children: a 16-year experience. Acta Chir Belg. 2007; 107:49–52.
40. Riffat F, Cheng A. Pediatric caustic ingestion: 50 consecutive cases and a review of the literature. Dis Esophagus. 2009; 22:89–94.
41. Anderson KD, Rouse TM, Randolph JG. A controlled trial of corticosteroids in children with corrosive injury of the esophagus. N Engl J Med. 1990; 323:637–640.
42. Fulton JA, Hoffman RS. Steroids in second degree caustic burns of the esophagus: a systematic pooled analysis of fifty years of human data: 1956–2006. Clin Toxicol (Phila). 2007; 45:402–408.
43. Oh BJ, Kim W, Cho GC, et al. Research on poisoning data collection using toxic exposure surveillance system: retrospective preliminary survey. J Korean Soc Clin Toxicol. 2006; 4:32–43.
Table 1.
Characteristic | Total (n=140) | Early group (n=50) | Late group (n=90) | p-value |
---|---|---|---|---|
Age (yr) | 43.7±17.4 | 43.6±15.8 | 43.8±18.2 | 0.959 |
Gender | 0.898 | |||
Male | 57 (40.7) | 20 (40.0) | 37 (41.1) | |
Female | 83 (59.3) | 30 (60.0) | 53 (58.9) | |
Co-morbidity | 48 (34.3) | 15 (30) | 33 (36.7) | 0.426 |
Diabetes mellitus | 7 (5.0) | 2 (4.0) | 5 (5.6) | |
Hypertension | 7 (5.0) | 4 (8.0) | 3 (3.3) | |
Depression | 19 (13.6) | 4 (8.0) | 15 (16.7) | |
Other psychiatric disorder a | 12 (8.7) | 5 (10.0) | 7 (7.8) | |
Etc. b | 3 (2.1) | 0.0 (0.0) | 3 (3.3) | |
Purpose of caustic ingestion (suicide/accident/unknown) | 96/42/2 | 32/18/0 | 64/24/2 | 0.381 |
(68.6/30.0/1.4) | (64/36/0) | (71.1/26.7/2.2) | ||
Caustic agents (acid/alkali) | 70/70 (50/50) | 40/10 (80/20) | 30/60 (33.3/66.7) | <0.001 |
Table 2.
Caustic agent |
Total (n=140) |
Suicide (n=96) |
Accident (n=42) |
|||
---|---|---|---|---|---|---|
Early group (n=50) | Late group (n=90) | Early group (n=32) | Late group (n=64) a | Early group (n=18) | Late group (n=24) a | |
Acid | 40 (80.0) | 30 (33.3) | 23 (71.9) | 24 (37.5) | 17 (94.4) | 6 (25.0) |
Glacial acetic acid | 21 (42.0) | 18 (20.0) | 10 (31.2) | 14 (21.9) | 11 (61.1) | 4 (16.7) |
Hydrochloric acid | 13 (26.0) | 9 (10.0) | 10 (31.2) | 8 (12.5) | 3 (16.7) | 1 (4.2) |
Acid etc. | 6 (12.0) | 3 (3.3) | 3 (9.4) | 2 (3.1) | 3 (16.7) | 1 (4.2) |
Alkali | 10 (20.0) | 60 (66.7) | 9 (28.1) | 40 (62.5) | 1 (5.6) | 18 (75.0) |
Rox | 4 (8.0) | 37 (41.1) | 3 (9.4) | 27 (42.2) | 1 (5.6) | 10 (41.7) |
Lye | 5 (10.0) | 5 (5.6) | 5 (15.6) | 3 (4.7) | 0 (0) | 2 (8.3) |
Alkali etc. | 1 (2.0) | 18 (20.0) | 1 (3.1) | 10 (15.6) | 0 (0) | 6 (25.0) |
Table 3.
Endoscopic grade | Early group (n=46)a | Late group (n=87)a p-value |
---|---|---|
Esophagus | 0.012 | |
≤ Grade 2a | 27 (58.7) | 69 (79.3) |
≥ Grade 2b | 19 (41.3) | 18 (20.7) |
Grade 0 | 2 (4.3) | 27 (30.0) |
Grade 1 | 8 (17.4) | 20 (21.1) |
Grade 2a | 17 (37.0) | 22 (25.6) |
Grade 2b | 7 (15.2) | 5 (6.7) |
Grade 3a | 7 (15.2) | 4 (4.6) |
Grade 3b | 5 (10.9) | 9 (10.3) |
Stomach | 0.101 | |
≤ Grade 2a | 29 (67.4) | 70 (80.5) |
≥ Grade 2b | 14 (32.6) | 17 (19.5) |
Grade 0 | 0 (0) | 26 (29.9) |
Grade 1 | 11 (23.9) | 24 (27.6) |
Grade 2a | 18 (39.1) | 20 (23.0) |
Grade 2b | 6 (13.0) | 7 (8.0) |
Grade 3a | 6 (13.0) | 4 (4.6) |
Grade 3b | 2 (4.3) | 6 (6.9) |
Non-available | 3 (6.5) | 0 (0) |
Duodenum | 0.10 | |
≤ Grade 2a | 37 (94.9) | 84 (92.2) |
≥ Grade 2b | 2 (5.1) | 0 (7.8) |
Grade 0 | 21 (45.7) | 70 (80.5) |
Grade 1 | 13 (28.3) | 10 (11.5) |
Grade 2a | 3 (6.5) | 3 (3.4) |
Grade 2b | 1 (2.2) | 0 (0) |
Grade 3a | 0 (0) | 0 (0) |
Grade 3b | 1 (2.2) | 0 (0) |
Non-available | 7 (15.2) | 4 (4.6) |
Table 4.
Treatment modality | Early group (n=50)a | Late group (n=90)a | p-value |
---|---|---|---|
Gastric lavage | 7 (14) | 2 (2.2) | 0.010 |
NPO b | 4 (8.7) | 27 (31.0) | 0.005 |
Antibiotics c | 21 (45.7) | 23 (26.4) | 0.033 |
Steroid | 19 (38) | 46 (51.1) | 0.159 |
Table 5.
Complication | Early group (n=50) | Late group (n=90) | p-value |
---|---|---|---|
Transfer or voluntarily discharge | 17 (34.0) | 23 (25.6) | 0.331 |
Hospital stay (day) a | 14.0 (9.50-20.50) | 5.0 (3.00-13.0) | <0.001 |
ICU admission (day) a | 11 (22) | 21 (23.3) | 0.857 |
0 (0.0-0.0/0-20) | 0 (0.0-0.0/0-22) | 0.385 | |
Mortality | 0 (0) | 3 (3.3) | 0.076 |
Acute complication | 6 (12.0) | 8 (8.9) | 1.000 |
Stricture | 7 (14.0) | 9 (10.0) | 0.581 |
Table 6.
Esophageal endoscopic grade | n (%) | OR b (95% CI) | p-value |
---|---|---|---|
Acute complication a | |||
Grade 0–2a | 4/96 (4.2) | 1.0 | |
Grade 2b-3a | 3/23 (13.0) | 2.41 (0.05-12.99) | 0.306 |
Grade 3b | 6/14 (42.9) | 14.43 (3.21-64.81) | <0.001 |
Late sequelae-stricture | |||
Grade 0–2a | 2/96 (2.1) | 1.0 | |
Grade 2b-3a | 2/23 (8.7) | 1.0 | |
Grade 3b | 11/14 (78.6) | 129.19 (21.44-778.16) | <0.001 |